CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 18 enrolled
Drug / intervention
Caspofungindrug
Likely dose
Caspofungin 70mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01062165
NCT01062165Phase 4Completed
CompareCT.gov

Population Pharmacokinetic Analysis of Caspofungin in Overweight and Obese Volunteers

Texas Tech University Health Sciences Center·interventional·Posted Feb 4, 2010·Updated Feb 10, 2017

In Brief

A Phase 4 clinical trial evaluating Caspofungin for Obesity and Fungal Infection. Completed, enrolled 18 participants across 1 site.

Detailed Summary

This study will find how weight affects the dosing of a drug called caspofungin. Currently, the amount of caspofungin a patient receives is the same regardless of the patient's weight.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Fungal Infection
CountriesUnited States
CollaboratorsNational Center for Research Resources (NCRR), University of Texas Southwestern Medical Center

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 4, 2010
Enrollment StartFeb 1, 2010
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 16.4 years ago

Interventions

Caspofungindrug

Caspofungin 70mg IV (each volunteer will only receive one dose of the study drug)